Login
Toggle navigation
Videos
Categories
Trending
Alan Beasley, CEO, Hydroponics Company Ltd
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
OnMarket IPO: The Hydroponics Company (ASX:THC) interview with Alan Beasley & Andrew Beehag
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Maximizing Roth Contributions for High-Income Earners: A Simple Guide
00:10:00
Jean-François Fallacher, CEO of Orange Polska, discusses his goals for 2020 and collaborations with Ericsson and Orange France.
00:10:00
Interview with Leak Resources at 121 Mining Investment London 2019
00:10:00
Core Tin's Strategic Role in Securing UK Tin Supply Amid Global Shortages
00:10:00
Interview with Nicola Turra, CEO of ABP Nocivelli | Beatrice Bonfadini - President of azienda bresciana petroli nocivelli spa
00:10:00
Positive Quarterly Results and Long-Term Goals | Dr Maciej Wieczorek, CEO,Celon Pharma SA.
00:10:00
Do You Need Life Insurance? Key Reasons and Considerations
00:10:00
Evolution and Triumphs in the Nordic Tech Arena: A Decade of Innovation and Global Impact | Tellef Thorleifsson, CEO, Norfund.
00:10:00
Indigenous Prosperity and Natural Resources: A Future Dialogue | Sheldon Wuttunee - CEO of critical minerals centre of excellence
00:10:00
Deepinder Goyal, CEO of Zomato, Confident of 10x Profit in Five Years | Deepinder Goyal, CEO , Zomato Ltd.
00:10:00
Helping entrepreneurs turn early-stage concepts into tomorrow's industry-leading companies|Matt Mosman,Partner,Pelion Venture Partners
00:10:00
Palsatech's Riku Aho Discusses Company Operations on RTL7's 'Business in Europe